11-1929072-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006757.4(TNNT3):c.83-48A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 1,610,974 control chromosomes in the GnomAD database, including 525,594 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.81 ( 49988 hom., cov: 34)
Exomes 𝑓: 0.81 ( 475606 hom. )
Consequence
TNNT3
NM_006757.4 intron
NM_006757.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.709
Publications
9 publications found
Genes affected
TNNT3 (HGNC:11950): (troponin T3, fast skeletal type) The binding of Ca(2+) to the trimeric troponin complex initiates the process of muscle contraction. Increased Ca(2+) concentrations produce a conformational change in the troponin complex that is transmitted to tropomyosin dimers situated along actin filaments. The altered conformation permits increased interaction between a myosin head and an actin filament which, ultimately, produces a muscle contraction. The troponin complex has protein subunits C, I, and T. Subunit C binds Ca(2+) and subunit I binds to actin and inhibits actin-myosin interaction. Subunit T binds the troponin complex to the tropomyosin complex and is also required for Ca(2+)-mediated activation of actomyosin ATPase activity. There are 3 different troponin T genes that encode tissue-specific isoforms of subunit T for fast skeletal-, slow skeletal-, and cardiac-muscle. This gene encodes fast skeletal troponin T protein; also known as troponin T type 3. Alternative splicing results in multiple transcript variants encoding additional distinct troponin T type 3 isoforms. A developmentally regulated switch between fetal/neonatal and adult troponin T type 3 isoforms occurs. Additional splice variants have been described but their biological validity has not been established. Mutations in this gene may cause distal arthrogryposis multiplex congenita type 2B (DA2B). [provided by RefSeq, Oct 2009]
TNNT3 Gene-Disease associations (from GenCC):
- distal arthrogryposis type 2B1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathyInheritance: AR Classification: STRONG Submitted by: G2P
- arthrogryposis, distal, type 2B2Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- nemaline myopathyInheritance: AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen
- digitotalar dysmorphismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Sheldon-hall syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 11-1929072-A-G is Benign according to our data. Variant chr11-1929072-A-G is described in ClinVar as Benign. ClinVar VariationId is 260032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.902 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNNT3 | NM_006757.4 | c.83-48A>G | intron_variant | Intron 6 of 15 | ENST00000278317.11 | NP_006748.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNNT3 | ENST00000278317.11 | c.83-48A>G | intron_variant | Intron 6 of 15 | 5 | NM_006757.4 | ENSP00000278317.6 |
Frequencies
GnomAD3 genomes AF: 0.809 AC: 123114AN: 152106Hom.: 49944 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
123114
AN:
152106
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.811 AC: 202732AN: 250064 AF XY: 0.803 show subpopulations
GnomAD2 exomes
AF:
AC:
202732
AN:
250064
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.806 AC: 1176185AN: 1458750Hom.: 475606 Cov.: 36 AF XY: 0.803 AC XY: 582616AN XY: 725864 show subpopulations
GnomAD4 exome
AF:
AC:
1176185
AN:
1458750
Hom.:
Cov.:
36
AF XY:
AC XY:
582616
AN XY:
725864
show subpopulations
African (AFR)
AF:
AC:
26694
AN:
33454
American (AMR)
AF:
AC:
39714
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
18580
AN:
26118
East Asian (EAS)
AF:
AC:
36197
AN:
39688
South Asian (SAS)
AF:
AC:
60901
AN:
86228
European-Finnish (FIN)
AF:
AC:
41838
AN:
51720
Middle Eastern (MID)
AF:
AC:
4689
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
899246
AN:
1110724
Other (OTH)
AF:
AC:
48326
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
13043
26085
39128
52170
65213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20842
41684
62526
83368
104210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.809 AC: 123219AN: 152224Hom.: 49988 Cov.: 34 AF XY: 0.808 AC XY: 60162AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
123219
AN:
152224
Hom.:
Cov.:
34
AF XY:
AC XY:
60162
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
33282
AN:
41544
American (AMR)
AF:
AC:
13116
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
2488
AN:
3472
East Asian (EAS)
AF:
AC:
4771
AN:
5162
South Asian (SAS)
AF:
AC:
3462
AN:
4826
European-Finnish (FIN)
AF:
AC:
8626
AN:
10612
Middle Eastern (MID)
AF:
AC:
242
AN:
294
European-Non Finnish (NFE)
AF:
AC:
54723
AN:
67988
Other (OTH)
AF:
AC:
1765
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1268
2537
3805
5074
6342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2897
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis, distal, type 2B2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.